|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07C 237/14 | |
| A61K 31/16 | |||
| A61P 11/00 | |||
| A61P 37/00 | |||
| C07D 233/58 |
| (11) | Number of the document | 2582660 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11795278.8 |
| Date of filing the European patent application | 2011-06-16 | |
| (97) | Date of publication of the European application | 2013-04-24 |
| (45) | Date of publication and mention of the grant of the patent | 2015-07-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2011/052613 |
| Date | 2011-06-16 |
| (87) | Number | WO 2011/158197 |
| Date | 2011-12-22 |
| (30) | Number | Date | Country code |
| 1050618 | 2010-06-16 | SE |
| (72) |
AYESA, Susana, SE
GRABOWSKA,Urszula, SE
HEWITT, Ellen, SE
JÖNSSON, Daniel, SE
KLASSON, Björn, SE
KAHNBERG, Pia, SE
LUNDGREN, Stina, SE
TEJBRANT, Jan, SE
WIKTELIUS, Daniel, SE
|
| (73) |
Medivir UK Ltd,
The Mansion Chesterford Research Park, Little Chesterford Essex CB10 1XL,
GB
|
| (54) | NEW CATHEPSIN S PROTEASE INHIBITORS, USEFUL IN THE TREATMENT OF E.G. AUTOIMMUNE DISORDERS, ALLERGY AND CHRONIC PAIN CONDITIONS |
| NEW CATHEPSIN S PROTEASE INHIBITORS, USEFUL IN THE TREATMENT OF E.G. AUTOIMMUNE DISORDERS, ALLERGY AND CHRONIC PAIN CONDITIONS |